Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.

Psycho-oncology - 1 Feb 2013

Aspinwall Lisa G, Taber Jennifer M, Leaf Samantha L, Kohlmann Wendy, Leachman Sancy A

Abstract excerpt

OBJECTIVE: CDKN2A/p16 mutations confer 76% lifetime risk of melanoma and up to 17% lifetime risk of pancreatic cancer. Our objective was to determine the short- and long-term impact of CDKN2A/p16 genetic counseling and test reporting on psychological distress, cancer worry, and perceived costs and benefits of testing. METHODS: Prospective changes in anxiety, depression, and cancer worry following CDKN2A/p16...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anxiety
Share to Depression
Share to Genes, p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Longitudinal Studies

Share to Melanoma

Share to Pancreatic Neoplasms

Share to United States

Source

Identifiers

PMID: 23382133
DOI: 10.1002/pon.2080

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.PMID 23382133Read ↗

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.Semantic proximity Read ↗

Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic VariantsSemantic proximity Read ↗

Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.Semantic proximity Read ↗

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.Semantic proximity Read ↗

Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.Semantic proximity Read ↗

Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: A focus group study.Semantic proximity Read ↗

Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant.Semantic proximity Read ↗

Clinical applications of melanoma genetics.Semantic proximity Read ↗

Predictors of psychological distress among individuals with a strong family history of malignant melanoma.Semantic proximity Read ↗

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.Semantic proximity Read ↗

Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.Semantic proximity Read ↗

Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.